NEW YORK, Jan. 7, 2019 /PRNewswire/ -- Rowley Law PLLC
is investigating potential claims against Loxo Oncology, Inc.
(NASDAQ: LOXO) and its board of directors for breach of fiduciary
duty concerning the proposed acquisition of the company by Eli
Lilly and Company (NYSE: LLY). Stockholders will receive
$235.00 for each share of Loxo
Oncology, Inc. stock that they hold. The transaction is valued at
approximately $8 billion and is
expected to close by the end of the first quarter of 2019.
If you are a stockholder of Loxo Oncology, Inc. and are
interested in obtaining additional information regarding this
investigation, please visit us
at: http://www.rowleylawpllc.com/investigation/loxo. You may
also contact Shane Rowley, Esq. at
Rowley Law PLLC, 50 Main Street Suite 1000, White Plains, NY 10606, by email at
info@rowleylawpllc.com, or by telephone at 914-400-1920 or
844-400-4643 (toll-free).
Rowley Law PLLC represents shareholders nationwide in class
actions and derivative lawsuits in complex corporate litigation.
For more information about the firm and its attorneys, please visit
http://www.rowleylawpllc.com.
Attorney Advertising. Prior results do not guarantee a similar
outcome.
View original
content:http://www.prnewswire.com/news-releases/alert-rowley-law-pllc-is-investigating-proposed-acquisition-of-loxo-oncology-inc-300774258.html
SOURCE Rowley Law PLLC